ABACAVIR SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Abacavir Sulfate, and what generic alternatives are available?
Abacavir Sulfate is a drug marketed by Aurobindo Pharma Ltd, Hetero Labs Ltd Iii, Apotex Inc, Cipla, Mylan Pharms Inc, Strides Pharma, Norvium Bioscience, Aurobindo Pharma, Chartwell Rx, Laurus, Teva Pharms Usa, Zydus Pharms, and Lupin Ltd. and is included in seventeen NDAs.
The generic ingredient in ABACAVIR SULFATE is abacavir sulfate; lamivudine; zidovudine. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the abacavir sulfate; lamivudine; zidovudine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ABACAVIR SULFATE?
- What are the global sales for ABACAVIR SULFATE?
- What is Average Wholesale Price for ABACAVIR SULFATE?
Summary for ABACAVIR SULFATE
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 17 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 65 |
Patent Applications: | 2,847 |
DailyMed Link: | ABACAVIR SULFATE at DailyMed |
Paragraph IV (Patent) Challenges for ABACAVIR SULFATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ZIAGEN | Oral Solution | abacavir sulfate | 20 mg/mL | 020978 | 1 | 2012-12-27 |
ZIAGEN | Tablets | abacavir sulfate | 300 mg | 020977 | 1 | 2009-01-28 |